Does Insurance Cover Wegovy for PCOS?
PCOS alone usually isn't enough — here's exactly when Wegovy gets covered, and how to get approved.
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links are partner links. They never change our answer, the prices we show, or what we tell you below.
Does insurance cover Wegovy for PCOS? Usually not for PCOS by itself. Wegovy is FDA-approved for weight management, heart-risk reduction, and a liver disease called MASH — but it has no PCOS approval. Most plans won't pay when "PCOS" is the only reason on the prescription. You're far more likely to get covered when the prescription points to a route your plan already recognizes.
Here's the part almost no other page will tell you: at least one major insurer — Cigna — lists PCOS by name as a qualifying condition. Many others, like Aetna, don't. We read the actual policy language, checked real 2026 prices, and pulled a real insurance appeal record.
Your situation at a glance
| If this is you | Does insurance usually cover Wegovy? | Your fastest next move |
|---|---|---|
| PCOS only — no obesity, no other covered condition | Usually no | Ask your plan which conditions would qualify. |
| PCOS + BMI 30 or higher | Maybe (the most common path) | Check if your plan covers anti-obesity meds, then prior authorization. |
| PCOS + BMI 27-29.9 + another weight-related condition | Maybe — and stronger | Find out if your plan counts PCOS, or which other condition does. |
| PCOS + heart disease + extra weight | More likely | Ask about Wegovy's cardiovascular route. |
| PCOS + MASH (liver scarring, stages F2-F3) | Possible — Wegovy injection only | Ask about the MASH route with specialist records. |
| Your plan excludes weight-loss drugs | Usually denied | Check if another approved route or an appeal applies. |
What we actually verified for this page — Last verified:
- Wegovy's current FDA label and approved uses
- Cigna and Aetna prior-authorization criteria (which conditions count)
- NovoCare self-pay prices and savings-card terms
- Medicare GLP-1 Bridge rules and dates straight from CMS
- Massachusetts Medicaid's current GLP-1 rules
- Ro's current Wegovy pricing, free coverage checker, and its limits
- The 2023 international PCOS guideline language on GLP-1 medicines
- A real, public insurance appeal record involving a PCOS patient (Massachusetts Office of Medicaid Board of Hearings, Appeal No. 2205321)
Find your coverage route in 60 seconds
Answer five quick questions — your insurance type, BMI range, PCOS diagnosis, any other conditions, and whether you've been denied — and get the exact route to check first, the documents to gather, and your realistic cost.
Start the free coverage path finder →Does insurance cover Wegovy for PCOS?
Usually not for PCOS alone — but "PCOS alone" is rarely the whole story. Insurance plans don't really ask "do you have PCOS?" They ask "do you meet a covered reason for Wegovy?" That reason is almost always your weight (or a condition like type 2 diabetes), with PCOS as supporting context.
The reframe that saves people weeks of frustration: You searched "does insurance cover Wegovy for PCOS," picturing your diagnosis as the key that unlocks the door. For most plans, it isn't the key — your weight criteria or a covered companion condition is. PCOS can strengthen your case, and on some plans it counts directly (more on that below). But if you walk in expecting "I have PCOS" to be enough on its own, you'll likely get denied.
The data hints at this. One large analysis found GLP-1 prescribing among women with PCOS jumped from 2.4% in 2021 to 17.6% in 2025 — and nearly all of those patients also had obesity and/or type 2 diabetes, the conditions these drugs are actually approved for (Truveta, 2025). That's a prescribing trend, not proof of who got paid. But it points to the real pattern: when coverage comes through for a PCOS patient, it almost always comes through a route the plan already recognizes.
So don't ask, "Does PCOS qualify?" Ask, "Does my plan cover Wegovy through obesity, a comorbidity, heart disease, or MASH — and does it count PCOS as one of those conditions?" That single shift is the difference between an approval and a denial.
Is Wegovy FDA-approved for PCOS?
No. Wegovy is not FDA-approved to treat PCOS. It's approved for three things: long-term weight management in qualifying adults and teens, lowering heart-attack and stroke risk in adults with heart disease plus excess weight, and treating a liver disease called MASH — and that single fact is why insurers usually won't cover Wegovy for PCOS on its own.
If you're hoping the words "I have PCOS" will unlock coverage, on most plans they won't. Wegovy has no PCOS indication, so plans treat a PCOS-only request as "off-label" and routinely deny it. But that's not a dead end — the fix usually isn't switching drugs. It's documenting the reason insurers already pay for.
| Wegovy's FDA-approved use | Who it's for | Why it matters for your coverage |
|---|---|---|
| Chronic weight management | Adults with obesity (BMI 30+); adults with overweight (BMI 27+) plus at least one weight-related condition; teens 12+ with obesity | The most common route for a PCOS patient. This is where your BMI -- and sometimes PCOS itself -- does the work. |
| Cardiovascular (heart) risk reduction | Adults with known heart disease and obesity or overweight | A separate route, evaluated on its own criteria -- often without the weight route's 6-month lifestyle requirement. |
| MASH (metabolic dysfunction-associated steatohepatitis -- serious liver scarring without cirrhosis, stages F2-F3) | Adults with moderate-to-advanced liver fibrosis | A real route only for Wegovy injection -- the tablets do NOT carry the MASH approval. PCOS is a recognized risk factor for MASH. |
Source: Wegovy FDA prescribing information; Drugs.com FDA approval history.
A few things this does not mean:
- It does not mean a doctor can't prescribe Wegovy to someone with PCOS. They can -- many do.
- It does not mean insurance will pay just because you have PCOS.
- It does not mean compounded semaglutide is the same thing as Wegovy.
Does the Wegovy pill have the same insurance rules as the injection?
For weight management and heart-risk reduction, the rules are essentially the same — for MASH, only the injection is approved. Both the Wegovy pill and the Wegovy pen are FDA-approved for adult weight management and cardiovascular risk reduction, so plans generally apply the same BMI and prior-authorization criteria to both. The MASH route is the exception: it's approved only for the injection, not the tablets. One practical heads-up — even if you're already approved on the pen, switching to the pill may trigger a separate prior authorization.
So when is Wegovy covered if you have PCOS? The 4 real routes
There are four realistic ways a PCOS patient gets Wegovy covered, and "PCOS" is only one of them. You only need one to open.
Route 1 — The weight route (most common) Most common
You qualify if you have a BMI of 30 or higher, or a BMI of 27 or higher plus a weight-related condition your plan accepts. This is the door most PCOS patients walk through, because PCOS so often comes with extra weight and insulin resistance. Whether PCOS itself counts as the "weight-related condition" depends entirely on your plan -- and that's the make-or-break detail we break down next.
Route 2 — The heart route Strong
Wegovy is approved to lower the risk of major heart events (heart attack, stroke, cardiovascular death) in adults who have established heart disease plus obesity or overweight. If that's documented in your records, it's evaluated under its own criteria -- and on some plans (Aetna's, for example) the heart route skips the 6-month weight-management requirement.
Route 3 — The MASH route (injection only) Strong -- injection only
MASH means serious liver scarring from fat in the liver, without cirrhosis. Wegovy injection is approved for adults with moderate-to-advanced MASH (stages F2-F3). Here's a connection most people miss: PCOS is itself a recognized risk factor for MASH (Novo Nordisk's Wegovy MASH materials list it). So if a liver specialist has documented MASH F2-F3, this becomes a genuine coverage route -- but only for the injection, not the pill.
Route 4 — The plan-lists-PCOS route Strong on matching plans
A few plans name PCOS directly in their criteria. If yours does and you meet the BMI threshold, PCOS can be the qualifying condition itself. That's the difference between Cigna and Aetna -- which we show in plain language right below.
| Your documented reason | Coverage strength | Quick note |
|---|---|---|
| PCOS, by itself | Weak alone | Helps your case if your plan lists it; not a Wegovy approval on its own. |
| BMI 30 or higher | Stronger | Standard obesity route -- if your plan covers weight-loss meds at all. |
| BMI 27+ + high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, etc. | Stronger | Depends on your plan's accepted-conditions list. |
| Heart disease + overweight/obesity | Strong | Matches Wegovy's heart route. |
| MASH, stages F2-F3 | Strong (injection only) | Needs liver/fibrosis documentation. |
| Plan excludes weight-loss meds | Weak | A prior authorization won't fix an exclusion. |
Does PCOS count as a qualifying condition? Cigna vs. Aetna
Sometimes — and it depends on your insurer, not on PCOS. We read the actual policies, and the contrast is real: Cigna's published GLP-1 prior-authorization policy includes "polycystic ovarian syndrome" on its list of qualifying conditions. Aetna's commonly published list does not name PCOS. Same diagnosis, different answer.
| Insurer (published policy) | Lists PCOS as a qualifying condition? | What it means for you |
|---|---|---|
| Cigna (GLP-1 weight-loss PA policy) | Yes -- "polycystic ovarian syndrome" appears among qualifying conditions for the BMI 27+ route | With Cigna, PCOS plus a BMI of 27+ can be your qualifying condition. One nuance: some Cigna programs require two listed conditions -- confirm your specific plan. |
| Aetna (commercial Wegovy PA criteria) | Not named -- the commonly published list is high blood pressure, type 2 diabetes, and high cholesterol | With Aetna, you'll likely need one of those conditions documented at BMI 27+, plus (on most plans) about 6 months of structured weight-management history. PCOS supports the story but isn't on the named list. |
Sources: Cigna GLP-1 prior-authorization coverage policy; Aetna non-Medicare Wegovy PA criteria. Plans update these lists often -- a condition not on a named list isn't always an automatic "no," but you shouldn't count on PCOS alone to carry an Aetna-style plan. Confirm yours before you spend money.
The one sentence to take to your insurer or doctor:
"Does my plan cover Wegovy for weight management, what BMI and condition criteria apply, does it count PCOS as a qualifying condition, and is this a prior-authorization issue or a plan exclusion?"Want to know which side your plan is on — without guessing?
You can check your Wegovy coverage in a couple of minutes, before you pay for any visit or membership.
Check my coverage free with Ro → (sponsored affiliate link, opens in a new tab)Sponsored link · commercial & FEHB plans only · free coverage report, no commitment
The PCOS + Wegovy coverage likelihood matrix
Our scoring of how likely Wegovy coverage is for each PCOS situation, based on current FDA labeling, payer policies, and program rules. We score each scenario 1–5, where 1 = weak and 5 = strongest.
This is an editorial map, not a guarantee -- your plan's exact language and your documentation decide the outcome.
| Your scenario | More likely route | What insurers may want | Likelihood (1-5) | Best next step |
|---|---|---|---|---|
| PCOS only, normal weight, no other condition | None unless your plan has an unusual exception | Diagnosis, formulary check | 1 | Treat as a medical conversation; ask which use would be covered. |
| PCOS + BMI 30 or higher | Weight management (obesity) | BMI history, weight-loss attempts, PA form | 3 | Confirm your plan covers anti-obesity meds, then file PA. |
| PCOS + BMI 27+ + a weight-related condition | Overweight + comorbidity | BMI, the condition's records/labs, PA | 3-4 | Check whether your plan counts PCOS, or which condition it requires. |
| PCOS + BMI 27+, plan that lists PCOS (e.g., Cigna) | Overweight + plan-recognized condition | BMI, PCOS diagnosis, PA | 4 | Cite the policy language; submit BMI + PCOS documentation. |
| PCOS + heart disease + overweight/obesity | Cardiovascular risk reduction | Records of heart disease + weight status | 4-5 | Ask about the heart route; lifestyle requirement is often waived. |
| PCOS + MASH (F2-F3) | MASH (Wegovy injection) | Fibrosis staging, specialist notes | 4 | Ask about the MASH route; injection only. |
| Plan excludes weight-loss meds | Exception only if another approved use applies | Plan exclusion language | 1-2 | Find out if it's an exclusion vs. a PA denial -- different fixes. |
| Renewal after first approval | Continued-therapy criteria | Proof of response (often 5% or more weight loss) | Depends | Track your weight loss; many plans require about 5% to continue. |
What documents get a Wegovy prior authorization approved when you have PCOS?
A Wegovy prior authorization succeeds when it proves the insurer's actual criteria — not just that you have PCOS. That usually means your BMI and weight history, any qualifying conditions (and their labs), proof of past weight-loss efforts, and — if you're using the heart or MASH route — the matching specialist records. A complete, accurate packet is the single biggest difference between an approval and a "denied: criteria not met."
| Document | Why it helps | Who provides it |
|---|---|---|
| Current BMI + weight history | Establishes the obesity or overweight rule | Your clinician / chart |
| PCOS diagnosis | Supporting context (and the qualifier itself on plans that list it) | OB-GYN, endocrinologist, or primary care |
| Blood pressure readings | May document high blood pressure as a qualifying condition | Primary care / chart |
| Lipid (cholesterol) panel | May document high cholesterol | Lab / primary care |
| A1c, fasting glucose, or insulin-resistance labs | Documents metabolic risk (and diabetes/prediabetes if present) | Lab / primary care |
| Sleep apnea diagnosis | A commonly accepted qualifying condition when documented | Sleep specialist |
| Liver / MASH records (fibrosis staging) | Required for the MASH route; injection only | GI / hepatology |
| Heart disease records | Required for the cardiovascular route | Cardiologist / hospital |
| Prior weight-loss attempts | Many plans require a documented 3-6 month effort | Clinician / your own history |
| Current medication list | Safety and coverage documentation | Clinician |
| Pregnancy plans / contraception discussion | The PCOS guideline urges contraception where pregnancy is possible, since safety in pregnancy isn't established | Clinician / you |
A script you can copy and bring to your appointment:
"I have PCOS and I'm being evaluated for Wegovy. Can you tell me whether my plan covers Wegovy for chronic weight management, what BMI and condition criteria apply, whether my plan counts PCOS as a qualifying condition, and whether a denial would be a prior-authorization issue or a plan exclusion?"Need the diagnosis codes your doctor's office will use? See our guide to obesity ICD-10 codes for GLP-1 prior authorization.
Want this turned into a personalized checklist for your plan?
Build my Wegovy coverage checklist →How much does Wegovy cost — covered vs. denied (2026)?
If your plan covers Wegovy, you'll likely pay a copay — as little as $25 a month with the manufacturer savings card. If it doesn't, current 2026 self-pay prices start around $149 a month for the pill and $199 a month for starter pen doses, far below the roughly $1,349 list price.
| How you're paying | Likely monthly cost | Fine print |
|---|---|---|
| Commercial plan covers Wegovy + Wegovy Savings Card | As little as $25 | Commercial insurance only; FDA-approved use required; not for Medicare/Medicaid/TRICARE/VA. |
| Commercial plan excludes weight-loss meds → self-pay via NovoCare Pharmacy | Pill from $149; pen starter doses $199 for two fills (through June 30, 2026), then $349 (0.25-2.4 mg); $399 for Wegovy HD 7.2 mg | Self-pay; promo windows end mid-2026 -- confirm current pricing. |
| TrumpRx (trumprx.gov) | About $199 for starter pen doses, then about $349 | Self-pay with a valid prescription; can't be billed to insurance. |
| Medicare GLP-1 Bridge (weight route) | $50 flat | Part D enrollment + BMI rules; weight-management use only. Not a cash-pay price. |
| Telehealth -- Ro (cash-pay) | Pill $149 first month, then $199-$299; pen $199 first month, then $199-$399; membership $39 first month, then $149/mo (as low as $74/mo annual) | Cash-pay; includes a free coverage checker and insurance concierge; not for government insurance. |
| Telehealth -- Sesame (cash-pay / Costco) | Program from about $59-$99/mo; Wegovy injection $199 intro then about $349; pill from $149; Costco members about $349/mo | Cash-pay; broad brand menu; helps with prior authorization. |
Sources: NovoCare savings and self-pay pages; TrumpRx; Ro pricing; Sesame Care pricing. All figures verified — re-check before you buy.
Paying cash and want the lowest realistic starting price?
Compare current Wegovy cash prices and promos — they move every month.
See current Wegovy cash prices and availability on Ro → (sponsored affiliate link, opens in a new tab)Or check Sesame for Costco-member pricing →Sponsored links
Full breakdown: GLP-1 cost without insurance: FDA-approved cash-pay options.
Before you pay for a Wegovy telehealth program, check your coverage first
The single smartest money move here is to verify coverage before you pay for a visit or membership — because a denied prior authorization, an excluded benefit, and an uncovered medication are three different problems with three different fixes.
| Question to answer first | Why it matters |
|---|---|
| Is Wegovy on my plan's formulary (covered drug list)? | If not, you may need an exception or a different medicine. |
| Does my plan cover weight-loss meds at all? | If they're excluded, a prior authorization won't fix it. |
| Does my plan count PCOS as a qualifying condition? | Some plans (Cigna) do; many (Aetna-style) don't. |
| Will the provider actually file the prior-authorization paperwork? | This is often the gap between "prescribed" and "covered." |
| Path | What it does for you | What it can't solve | Best fit |
|---|---|---|---|
| Ro (free coverage checker + insurance concierge) | Checks your commercial coverage before you pay; files the prior authorization for FDA-approved Wegovy | Government insurance; a plan that excludes weight-loss drugs | Commercial insurance + you want the paperwork handled |
| NovoCare (manufacturer) | Free coverage check; savings card and self-pay pricing | Doesn't fight your prior authorization for you | Quick coverage check or manufacturer self-pay |
| Sesame / Costco | Cash-pay visits and Costco-member pricing | Doesn't bill most insurance for the drug | Cash-pay shoppers who want options |
| Your PCP / endocrinologist | Knows your history; can file the PA | Varies -- many offices don't deeply handle GLP-1 PAs | Your doctor already knows your plan's rules |
| Medicare GLP-1 Bridge | $50/month for eligible Part D members (weight route) | Not for PCOS alone; not commercial insurance | Medicare members who meet the BMI rules |
| State Medicaid | State-specific coverage for approved uses | Rarely covers weight loss; can't be billed by telehealth memberships | Medicaid members -- start with your state list |
Our one honest knock on the path we recommend most: Ro is not the cheapest option if your own doctor already knows your plan's Wegovy rules and will fight the prior authorization for you. Ro's membership ($39 first month, then $149/month, or as low as $74/month on an annual plan) is separate from the medication and isn't billed to insurance, and Ro's insurance concierge can't coordinate coverage through government plans like Medicaid, Medicare, or TRICARE. If you have government insurance, skip ahead to the Medicare and Medicaid sections below. But Ro's free coverage checker and prior-authorization concierge do the two things a busy doctor's office usually won't -- and for the person whose real problem is "will my plan cover this, and who's going to fight the paperwork," that's the friction gone.
Commercial insurance, and you want your answer before paying?
Check whether Ro can verify my Wegovy coverage and handle the prior authorization → (sponsored affiliate link, opens in a new tab)Sponsored link · Ro can't coordinate GLP-1 coverage through government insurance
What if your insurance denies Wegovy for PCOS?
A denial doesn't mean "never." First find out why — because a missing document, a "PCOS doesn't count" decision, a plan exclusion, and a "try another drug first" rule each have a different fix.
What a real Wegovy/PCOS denial looks like
In a public Massachusetts appeal decision (Office of Medicaid Board of Hearings, Appeal No. 2205321), a woman with PCOS, type 2 diabetes, and high blood pressure appealed after her Wegovy prior authorization was denied. She argued — reasonably — that her conditions combined drive her weight gain. The plan's criteria, though, defined Wegovy coverage strictly by the FDA weight rules (BMI 30+, or 27+ with a weight-related condition) and excluded drugs prescribed for non-covered uses.
The lesson: approvals hinge on a documented BMI plus a covered reason and a complete packet — not on naming PCOS. The appeals that win attach the BMI and the qualifying condition in writing.
| Denial reason | What it means | What to do |
|---|---|---|
| Missing prior authorization info | The plan needs more clinical proof | Resubmit with BMI, conditions, history, and your plan's exact criteria. |
| "PCOS not accepted" | The plan doesn't count PCOS | Ask which conditions do count, and whether another documented condition applies. |
| Plan exclusion | Weight-loss meds aren't covered under your plan | Ask HR/employer about plan design; appeal only helps if another approved use applies. |
| Step therapy | The plan wants another drug tried first | Ask what step is required and how to request an exception. |
| Formulary preference | The plan prefers a different GLP-1 | Ask if Wegovy can be approved when the preferred drug isn't appropriate. |
| Renewal denial | The plan wants proof it's working | Document your results; many plans require about 5% weight loss to continue. |
An appeal script you can use:
"Please send me the denial letter and the exact criteria used. I need to know whether this was denied because PCOS isn't accepted, because my BMI or condition documentation was incomplete, because Wegovy is excluded from my plan, or because another medication is preferred."Denied, or told PCOS isn't enough? Don't give up — map your next move.
Use the free quiz to find my route →Does Medicare cover Wegovy for PCOS?
Usually not for PCOS alone — but a temporary federal program now opens a $50/month door for weight loss. Traditional Medicare is barred by law from covering drugs used purely for weight loss, and PCOS isn't a covered route on its own. The exception: the new Medicare GLP-1 Bridge offers eligible Part D members Wegovy for $50 a month for weight reduction, starting July 1, 2026.
How the Medicare GLP-1 Bridge actually works (straight from CMS):
- What it is: a temporary CMS demonstration that covers weight-loss GLP-1s for a flat $50/month copay.
- When: July 1, 2026 through December 31, 2027.
- Which drugs: all formulations of Wegovy (injection and tablets), all formulations of Foundayo, and the KwikPen form of Zepbound -- but only when prescribed for weight management.
- Who qualifies: enrolled in Medicare Part D, and one of: BMI 35+ on its own; BMI 30+ with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a+; BMI 27+ with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.
- The catches: the $50 doesn't count toward your yearly out-of-pocket maximum, coupons can't stack on top of it, and if you have type 2 diabetes, sleep apnea, or MASH, those uses go through your regular Part D plan, not the Bridge.
| Medicare scenario | Likely answer |
|---|---|
| PCOS alone | Usually not a covered route. |
| Wegovy for heart-risk reduction | May be covered through Part D with documented heart disease + extra weight. |
| Wegovy for MASH | Goes through Part D (not the Bridge); injection route, with criteria. |
| Medicare GLP-1 Bridge | $50/month for eligible Part D members who meet the BMI rules -- weight-management use only. |
Learn more: Medicare GLP-1 Bridge: $50 copay explained · How to qualify for the Medicare GLP-1 Bridge program · Does Medicare cover Wegovy for weight loss?
Does Medicaid cover Wegovy for PCOS?
Medicaid coverage is state-by-state, and you can't generalize it — some states cover GLP-1s for weight loss under strict rules, some exclude weight-loss use entirely, and several are pulling back. As of early 2026, only about 13 states cover GLP-1s for obesity, down from roughly 16 in late 2025 (KFF). And PCOS by itself is rarely the covered route on any of them.
Massachusetts example: effective July 1, 2026, MassHealth (Massachusetts Medicaid) will stop covering Wegovy and Zepbound when used for weight loss entirely — coverage continues only for other approved uses like cardiovascular risk, MASH, and sleep apnea, with a new prior authorization required (MassHealth Pharmacy Facts, March 2026). Other states have their own preferred drugs, step rules, and exclusions.
If you're on Medicaid:
- Look up your state's Medicaid preferred drug list for Wegovy.
- Ask whether it's covered for obesity, the heart route, or MASH.
- Ask whether your state counts PCOS as a qualifying condition.
- Ask whether you must try a preferred drug first.
Telehealth providers like Ro can't coordinate GLP-1 coverage through Medicaid -- start with your state formulary and your own prescriber.
Is Wegovy actually a good fit for PCOS, or is this just about weight loss?
Wegovy isn't approved as a PCOS treatment, but for PCOS patients with higher weight, GLP-1 medicines may be considered as part of weight-management care — alongside lifestyle changes — according to the 2023 international PCOS guideline. That guideline stresses shared decisions with your doctor, side effects, contraception if pregnancy is possible, and the likelihood of long-term use.
What the research suggests, stated carefully: a 2025 meta-analysis of GLP-1 medicines in women with PCOS reported reductions in body weight, BMI, waist size, and insulin-resistance markers, with mostly mild side effects like nausea, vomiting, and dizziness; some studies also report lower testosterone levels (Scientific Reports, 2025). Insulin resistance is a core feature of PCOS — affecting an estimated 75% of patients (NCBI/PMC) — which is part of why these drugs draw interest.
To keep your expectations accurate, here's what we won't say, because it isn't established:
- Not "Wegovy treats PCOS."
- Not "Wegovy fixes your hormones."
- Not "Wegovy improves fertility."
- Not "Wegovy is clinically proven for PCOS."
- And not "compounded semaglutide is the same as Wegovy."
What's fair to say: for PCOS patients carrying extra weight, semaglutide may be part of a weight-management conversation with your clinician — and weight loss itself can improve insulin resistance and related risks.
Which path should you choose if you have PCOS and want Wegovy?
Your best next step depends on three things: your insurance type, which coverage route fits you, and whether your own doctor will handle the paperwork.
| Your situation | Best next step | Where to go |
|---|---|---|
| Commercial insurance, unsure if Wegovy is covered | Check coverage before paying for ongoing care | Ro free coverage checker or NovoCare |
| Commercial insurance, your doctor won't handle the paperwork | Use a concierge that files the prior authorization | Ro insurance concierge |
| Your PCP/endocrinologist already supports Wegovy | Start with them | Prior-authorization checklist above |
| Medicare | Check the heart route or the $50 Bridge | Medicare section above |
| Medicaid | Check your state formulary first | Medicaid section above |
| Plan excludes weight-loss drugs | Ask about other approved routes, appeal, or cash-pay | Cost ladder above |
| Not sure whether Wegovy or another option fits | Get a personalized plan | Free 60-second quiz |
Still not sure which GLP-1 program is right for you?
Our free 60-second matching quiz maps your most likely coverage route, what to bring to your doctor, and your realistic cost — personalized to your insurance, your situation, and your state. No payment, no pressure.
Take the free 60-second quiz →Or check commercial coverage free with Ro → (sponsored affiliate link, opens in a new tab)What people with PCOS worry about most
"I'm obese by BMI, but I don't think that's enough for insurance to cover it."
Common, and half-right: BMI matters, but it's your plan's specific Wegovy criteria, and whether you meet a covered route, that decide it. That's exactly why we mapped the routes and the Cigna-vs-Aetna difference above.
"I don't want to pay for a subscription before I know if insurance will cover the drug."
Right instinct. That's the whole reason we say: check coverage first, with a free tool, before paying for anything.
These reflect common, real-world concerns about cost and coverage — not statements about Wegovy's medical results, and not a promise of typical outcomes. Coverage and results vary by person and plan.
Frequently asked questions
- Does insurance cover Wegovy for PCOS?
- Usually not for PCOS alone, because Wegovy isn't FDA-approved for PCOS. Coverage becomes possible when the prescription fits a covered route -- obesity, overweight plus a qualifying condition, heart disease with excess weight, or MASH (stages F2-F3) for Wegovy injection.
- Is PCOS a qualifying diagnosis for Wegovy?
- Sometimes, depending on your plan. Cigna's published GLP-1 policy lists polycystic ovary syndrome as a qualifying condition; Aetna's commonly published list does not. Always confirm your specific plan's current criteria.
- What BMI do you need for Wegovy insurance coverage?
- Many commercial plans use a BMI of 30 or higher, or 27 or higher with at least one qualifying weight-related condition. Some require a higher BMI or more than one condition. The exact rule depends on your plan.
- Can Wegovy be prescribed off-label for PCOS?
- Yes -- a clinician can decide Wegovy is appropriate for you. But off-label prescribing doesn't guarantee coverage. Insurers usually approve based on FDA-approved or plan-recognized uses, not the off-label reason.
- Does the Wegovy pill have the same insurance rules as the injection?
- For weight management and heart-risk reduction, both the pill and injection are FDA-approved and follow similar rules. For MASH, only the injection is approved. You may need a separate prior authorization to switch from the pen to the pill.
- Does Wegovy help insulin resistance in PCOS?
- Research on GLP-1 medicines in PCOS suggests possible improvements in weight, BMI, and insulin-resistance markers, but Wegovy isn't approved specifically for PCOS or insulin resistance. Discuss it with your clinician.
- Will insurance cover Wegovy if I have PCOS and obesity?
- Possibly. Obesity (BMI 30+) is often the stronger route than PCOS itself -- but only if your plan covers anti-obesity medications and you meet the prior-authorization criteria.
- Will insurance cover Wegovy if I have PCOS and prediabetes?
- It depends on your plan's accepted-conditions list. Prediabetes can help your case, and it's a qualifying criterion under the Medicare GLP-1 Bridge at BMI 27+. Confirm whether your specific plan counts it.
- What if my insurance says weight-loss drugs are excluded?
- A plan exclusion is harder than a missing prior authorization. Ask whether Wegovy is covered for any other approved use, whether an exception is possible, and whether your employer's plan design can change.
- Does Medicare cover Wegovy for PCOS?
- Usually not for PCOS alone. It may be covered under another approved use, and the Medicare GLP-1 Bridge offers eligible Part D members Wegovy for $50/month for weight reduction from July 1, 2026 through December 31, 2027.
- Does Medicaid cover Wegovy for PCOS?
- It varies by state. Only about 13 states cover GLP-1s for obesity as of early 2026, several have pulled back, and some require a preferred drug first. Check your state Medicaid formulary.
- Can Ro help get Wegovy covered for PCOS?
- Ro can check commercial-insurance coverage for free and file prior-authorization paperwork for FDA-approved Wegovy. It can't coordinate coverage through Medicaid, Medicare, or TRICARE, and its membership cost is separate from the medication.
- What's the cheapest way to get Wegovy if insurance denies it?
- As of June 9, 2026, the lowest paths are the savings card (as little as $25 with covered commercial insurance), the Wegovy pill (from about $149), and NovoCare self-pay (from about $199 on promo for starter pen doses). Re-check current pricing before you buy.
How we researched this, and who wrote it
Last verified:
Who: Written by The RX Index Editorial Team. The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers.
How: We reviewed Wegovy's current FDA label and approved uses; the published prior-authorization criteria from Cigna and Aetna; NovoCare's coverage, savings-card, and self-pay pricing; the CMS Medicare GLP-1 Bridge program rules; Massachusetts Medicaid's current GLP-1 rules and the national Medicaid coverage count; Ro's current pricing, free coverage checker, and its limits; the 2023 international PCOS guideline language on GLP-1 medicines; a 2025 meta-analysis on GLP-1s in PCOS; and a real, public insurance appeal record involving a PCOS patient.
What goes out of date: Wegovy prices and promos (monthly), savings-card terms (monthly), Ro pricing (monthly), payer prior-authorization criteria (quarterly), the Medicare Bridge rules (quarterly), state Medicaid coverage (quarterly), and the FDA label (on any update).
Affiliate disclosure
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page are partner links, which means we may earn a commission if you start a program through them — at no extra cost to you. Partner relationships never change our editorial answer, the prices we show, or which option we recommend for your situation. We recommend Ro here because, for a coverage question on FDA-approved Wegovy, its free coverage checker and prior-authorization help genuinely fit what most commercially insured readers need. When a different path fits you better — your own doctor, Medicare, or Medicaid — we say so.Sources
- Wegovy FDA prescribing information (label) — accessdata.fda.gov · Drugs.com FDA approval history
- FDA cardiovascular indication announcement — fda.gov
- Wegovy MASH information (PCOS listed as a risk factor) — mash.wegovy.com
- Cigna GLP-1 weight-loss prior-authorization policy (PCOS listed) — static.cigna.com
- Aetna non-Medicare Wegovy prior-authorization criteria — aetna.com
- NovoCare savings card + self-pay pricing; coverage check — novocare.com; wegovy.com
- TrumpRx Wegovy self-pay pricing — trumprx.gov
- Ro GLP-1 Insurance Coverage Checker, pricing, and insurance page — ro.co
- Sesame Care weight-loss pricing — sesamecare.com
- Medicare GLP-1 Bridge (rules, dates, eligibility) — cms.gov; kff.org
- Massachusetts Medicaid GLP-1 rules and Appeal No. 2205321 — mass.gov; kff.org
- PCOS + GLP-1 evidence — Truveta (2025); Scientific Reports meta-analysis (2025, nature.com); insulin-resistance prevalence — NCBI/PMC; 2023 International Evidence-based PCOS Guideline — asrm.org
All facts current as of . Coverage rules, pricing, and program terms change frequently — confirm current details with your plan, provider, or CMS before you act.
Related guides from The RX Index
- Does insurance cover Wegovy for weight loss?
- Best GLP-1 for PCOS: Wegovy, Ozempic, Zepbound compared
- Best tirzepatide for PCOS
- Foundayo for PCOS: coverage and costs
- GLP-1 providers that accept insurance for PCOS
- Does insurance cover GLP-1 for prediabetes?
- Does insurance cover GLP-1 for heart disease?
- Does insurance cover GLP-1 for fatty liver?
- Does insurance cover GLP-1 for sleep apnea?
- Does insurance cover Foundayo?
- Best GLP-1 providers that accept insurance
- Best GLP-1 providers that help with prior authorization
- Free GLP-1 insurance coverage checkers: 7 tools compared
- GLP-1 cost without insurance: FDA-approved cash-pay options
- Medicare GLP-1 Bridge: $50 copay explained
- How to qualify for the Medicare GLP-1 Bridge program
- Free 60-second GLP-1 matching quiz